The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.
about
Preliminary Analysis of the Expression of Selected Proangiogenic and Antioxidant Genes and MicroRNAs in Patients with Non-Muscle-Invasive Bladder CancerDNA Repair Pathway Alterations in Bladder Cancer.Targeting nrf2 signaling to combat chemoresistance.Dual roles of NRF2 in tumor prevention and progression: possible implications in cancer treatmentKnockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer.New considerations on hormetic response against oxidative stress.Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer.The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer.The Prognostic Effect of Statin Use on Urologic Cancers: An Updated Meta-Analysis of 35 Observational Studies.Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell LinesABCF2, an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells.Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia.xCT expression modulates cisplatin resistance in Tca8113 tongue carcinoma cells.Overexpression of NRF2 is correlated with prognoses of patients with malignancies: A meta-analysis.Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer.Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.NRF2 Addiction in Cancer Cells.Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin.
P2860
Q28390776-FE839BA3-430F-4E31-9118-5B6ED3396779Q33607945-9BACEE49-743C-4720-B008-16DAFF466A0EQ34376139-DE506709-2B7A-4CC3-9A0C-39E11D1AF805Q35118710-DA4F8D3A-39AC-4200-9D74-23D893C2EFF6Q35176013-C1437B02-743B-4122-9FB1-E4469C115E71Q35333384-9D9BBE1B-1320-4478-8E20-54649DFDC1BFQ35809828-C3F53E6C-101A-4F8D-9087-4EC376475DE7Q35832954-2B7F0EDC-3F05-4456-810A-DD40455F7D62Q38584232-6B22FA09-8188-4039-9341-1FDA42E83809Q38647100-0F8400D6-F5E4-44F4-BD05-EE8199C11337Q38719990-6BB96D4A-EAA4-4EB2-99C2-AC03023B203FQ38869922-EF65E6AF-BEE8-4C9B-85D7-8FBA4908A4E3Q39224142-46CDA4E9-0A6C-4F25-9D57-425A0FBABAC8Q42722024-FF0F0EA5-0D6B-4860-811A-1828A9A0DA60Q47159406-34CB30E1-7AD1-4C88-AA2C-1818F7EB785FQ47327779-1E9D9779-59E2-4074-B1D4-EF6862F213FDQ49526759-E2486B17-1AF9-4950-A616-EF7A6E78D4DBQ49945078-A918DEA3-836C-4F18-A30F-11EAE2827F7EQ55519018-144B39E9-8CB1-4B7E-BE33-D1CDEEF5C663
P2860
The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.
@en
type
label
The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.
@en
prefLabel
The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.
@en
P2093
P50
P1433
P1476
The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer
@en
P2093
Annette Hayden
Gareth J Thomas
James Douglas
Katherine Gould
Lawrence Andrews
Matthew Sommerlad
P304
P356
10.1016/J.UROLONC.2014.02.006
P577
2014-05-16T00:00:00Z